Momenta Pharmaceuticals reports first quarter 2016 financial results
Momenta Pharmaceuticals reported a net loss of $(24.0) million, or $(0.35) per share for the 2016 first quarter versus a net loss of $(21.9) million, or $(0.40) per share for the 2015 same period. At March 31, 2016, the Company had cash, and equivalents, of $362.8 million. May 03, 2016